In modern medicinal chemistry, process development, and active pharmaceutical ingredient (API) manufacturing, introducing sterically hindered branched carboxylic acid scaffolds into small-molecule drug candidates provides a method for modifying metabolic stability and receptor binding affinity. Medications targeting cardiovascular diseases, metabolic disorders, and specialized enzyme pathways...